Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

#A4502 · immunohistochemistry

100

Citing papers

15.1k

Combined citations

Supplier page Find this product

Research areas

Gastrointestinal Tumor Research and Treatment37 Sarcoma Diagnosis and Treatment19 Gastrointestinal disorders and treatments10 Cell Adhesion Molecules Research8 Mast cells and histamine6 Soft tissue tumor case studies6 HER2/EGFR in Cancer Research5 Metastasis and carcinoma case studies5

Papers citing this product

1

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

New England Journal of Medicine·2002·4.4k cit.·DOI

2

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Clinical Cancer Research·2004·2.7k cit.·DOI

3

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Gastroenterology·2005·494 cit.·DOI

4

KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size

American Journal Of Pathology·2002·444 cit.·DOI

5

KIT Mutations Are Common in Testicular Seminomas

American Journal Of Pathology·2004·319 cit.·DOI

6

Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control

Immunity·2022·283 cit.·DOI

7

Prevalence of KIT Expression in Human Tumors

Journal of Clinical Oncology·2004·222 cit.·DOI

8

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

Modern Pathology·2009·211 cit.·DOI

9

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors

Modern Pathology·2010·210 cit.·DOI

10

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study

BMC Cancer·2007·206 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.